Companies: 10,795·Total market cap: $144.5T
Genmab A/S

Genmab A/S

GMABNASDAQHealthcare● Active
$24.83
$-0.32(-1.27%)
Market Cap$15.2B
P/E Ratio—
52W High$35.43
52W Low$20.225
EmployeesOwnershipInsider Trades

Genmab A/S (GMAB) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · GMAB · as of Feb 17, 2026

Latest filing snapshot

3,029
+347+12.94%vs prior year

Genmab A/S (GMAB) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global
Total Employees
3,029
Change (1Y)
+347
Growth % (1Y)
+12.94%
Revenue / Employee
$1.23M
Net Income / Employee
$318.2K
Market Cap
$15.2B

GMAB Employee Count

2019 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-173,029+347+12.94%
2025-02-122,682+478+21.69%
2024-02-142,204+544+32.77%
2023-02-221,660+448+36.96%
2022-02-161,212+431+55.19%
2021-03-29781+233+42.52%
2020-03-30548——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
55,000#2
Illumina, Inc.
ILMN
Illumina, Inc.
8,970#3
Genmab A/S
GMAB
Genmab A/SYOU
3,029#4
Incyte Corporation
INCY
Incyte Corporation
2,617#5
Exelixis, Inc.
EXEL
Exelixis, Inc.
1,147#6
Roivant Sciences Ltd.
ROIV
Roivant Sciences Ltd.
908#7
Royalty Pharma plc
RPRX
Royalty Pharma plc
75
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · GMAB peer comparison

About GMAB employees

GMAB Employees · Headcount

Genmab A/S (GMAB) employee data is sourced from the annual SEC 20-F filing. As of 2025, Genmab A/S had 3,029 full-time employees globally. Full-time employees only. Global consolidated headcount.

Genmab A/S employs 3,029 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.23M, reflecting the company's operational efficiency.

Genmab A/S's workforce increased by 347 (12.94%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Genmab A/S's revenue per employee of $1.23M positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

GMAB Employees · 5 questions

As of the latest SEC 20-F filing (2025), Genmab A/S had 3,029 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Genmab A/S employee counthow many employees does Genmab A/S haveGMAB total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-17